about
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...
Read More
1.24
-0.01
(-0.80%)
32,023
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..